Dr. Mark Gorovoy, M.D.
What this data tells you about Dr. Gorovoy
Dr. Mark Gorovoy is an ophthalmology specialist in Fort Myers, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Gorovoy performed 11,836 Medicare services across 6,563 unique beneficiaries.
Between the years covered by Open Payments, Dr. Gorovoy received a total of $7,631 from 32 pharmaceutical and/or device companies across 170 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Gorovoy is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Florida License Status
FL DOH · MQA| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 39771 | Clear | January 31, 2027 | — |
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Eye injection (Vabysmo/faricimab) | 3,720 | $29 | $55 |
| Office visit, established patient (20-29 min) | 1,480 | $64 | $180 |
| Office visit, established patient (30-39 min) | 977 | $85 | $200 |
| Retinal photography (fundus photo) | 844 | $26 | $180 |
| Retinal imaging (OCT scan) | 622 | $29 | $150 |
| Imaging of front third of eye using a special microscope | 561 | $28 | $200 |
| Comprehensive eye exam, established patient | 525 | $85 | $225 |
| Visual field test, extended | 328 | $43 | $265 |
| Corneal topography and eye depth measurement | 327 | $31 | $234 |
| Eye injection for retinal disease | 308 | $88 | $325 |
| Aflibercept eye injection (Eylea) | 302 | $692 | $1,500 |
| Optic nerve imaging (OCT scan) | 275 | $26 | $150 |
| Cataract surgery with lens implant | 274 | $421 | $2,500 |
| New patient office visit (45-59 min) | 207 | $112 | $300 |
| Removal of recurring cataract in lens capsule using a laser | 197 | $239 | $899 |
| New patient office visit, complex (60-74 min) | 132 | $165 | $370 |
| Compounded drug, not otherwise classified | 92 | $64 | $300 |
| Removal of eye fluid (vitreous) between lens and retina | 84 | $516 | $2,800 |
| Eye exam, established patient, focused | 78 | $54 | $175 |
| Transplantation of outer layer of corneal tissue | 76 | $911 | $3,500 |
| Exchange of prosthetic lens | 51 | $703 | $3,600 |
| 2d ultrasound scan of eye tissue and structures | 38 | $39 | $300 |
| Removal of eyelashes using forceps | 31 | $15 | $100 |
| Preparation of corneal tissue for transplant | 30 | $104 | $400 |
| Suture of iris and lens | 29 | $301 | $1,900 |
| Comprehensive eye exam, new patient | 27 | $96 | $290 |
| Creation of eye fluid drainage tract for treatment of glaucoma | 23 | $857 | $3,100 |
| Placement of amniotic membrane on eye surface for wound healing | 22 | $1,039 | $3,150 |
| Photography of content of eyes | 22 | $16 | $100 |
| New patient office visit (30-44 min) | 22 | $80 | $230 |
| Exam of visual field with intermediate testing | 19 | $34 | $165 |
| Scraping of cornea for diagnosis | 17 | $90 | $450 |
| Laser repair to improve eye fluid flow | 16 | $150 | $650 |
| Removal of scar tissue in eye (goniosynechiae) | 15 | $197 | $1,400 |
| Injection of air or liquid into eye | 15 | $118 | $575 |
| Removal of growth of cornea | 13 | $452 | $2,131 |
| Creation of shunt to improve eye fluid flow using tissue graft | 13 | $914 | $3,000 |
| Aspiration of lens material by fragmenting and aspiration | 13 | $326 | $2,400 |
| Ultrasound scan of cornea to determine thickness | 11 | $9 | $80 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
3.4 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Gorovoy is a clinical cardiology specialist, with above-average Medicare volume (top 11% in FL), with low-engagement industry engagement in the top 18% of FL peers, with 20 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Gorovoy experienced with eye injection (vabysmo/faricimab)?
Does Dr. Gorovoy receive payments from pharmaceutical companies?
How do Dr. Gorovoy's costs compare to other ophthalmologists in Fort Myers?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology